SECTM1 and neoplasm: Moreover, we checked the correlations between SECTM1 and immunomodulators expression, which were associated with features of tumor immune microenvironment (TIME) and the responses to immunotherapy, and the results showed that SECTM1 was positively correlated with most immunomodulators (Figure 2G).